Acadia Pharmaceuticals

Area Business Manager- Boston

Boston, Massachusetts, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, Pharmaceuticals, HealthcareIndustries

About Madrigal

Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction-associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis.

Endocrinology Area Business Manager

In this role, the Endocrinology Area Business Manager (ABM) will develop the territory business plan to achieve/exceed business and sales goals. You will work closely with your team and others across the organization to execute and deliver sales results that contribute to the overall performance, culture, and success of the organization. The Area Business Manager will play a pivotal role in promoting Madrigal and our groundbreaking first-to-market product addressing a significant patient unmet need. As an Area Business Manager, you will be responsible for building relationships with healthcare professionals, driving product adoption, and achieving sales goals within your designated territory. You will work closely with a cross-functional team to educate healthcare providers about the product profile of our innovative therapy.

The Endocrinology Area Business Manager will exhibit exceptionally strong clinical and business acumen. Existing relationships with local Endocrinologist HCPs are strongly preferred, as is working knowledge of market access and local impacts on territory-level business trends. The successful candidate will have an in-depth understanding of analytics to identify business opportunities and create actionable business plans for execution at launch. It is expected that this team member will display a high level of collaboration with cross-functional colleagues to create a positive customer experience for a diverse range of healthcare professionals.

Position Responsibilities

  • Develop a deep understanding of Resmetirom, its mechanism of action, and its clinical benefits.
  • Effectively communicate the clinical profile of the product to healthcare professionals.
  • Tailor product presentations to the specific needs and interests of each healthcare provider.
  • Evaluate office readiness to successfully identify patients and prescribe Rezdiffra.
  • Provide high-level education on local market access, payer requirements, and the Rezdiffra fulfillment process.
  • Ensure compliant pull-through of prescriptions in office to secure patients access to therapy and coordinate with Access Reimbursement Managers, as appropriate.
  • Execute the HCP peer-to-peer promotional and Disease State Education programs.
  • Create a detailed territory-level business plan to ensure successful launch execution post FDA approval.
  • Strategically plan and prioritize sales activities to maximize coverage and impact within your assigned territory.
  • Identify and target key healthcare providers, including endocrinologists and APPs.
  • Analyze and ensure utilization of sales and marketing tools and other resources provided to educate healthcare professionals on the company’s product(s).
  • Provide in-depth product training and education to healthcare professionals and their staff.
  • Stay up to date on the latest clinical data and treatment guidelines related to Endocrinologist specialty.
  • Ability to display a high level of clinical and business acumen; accountability for self to demonstrate mastery level of clinical knowledge, including assessments.
  • Develop an actionable business plan to execute effective sales strategies and tactics to drive product adoption to meet or exceed sales objectives.
  • Continuously analyze sales data and market trends to adapt your approach and improve performance.
  • Drive sales results while effectively and compliantly promoting the company’s product(s) to targeted HCPs.

Skills

Sales
Business Planning
Healthcare Professional (HCP) Relationship Building
Product Adoption
Analytics
Market Access
Endocrinology
Biopharmaceutical Sales

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI